The rating affirmation is based on several factors, including CentraCare’s regularly strong margins, dominant market position and stable liquidity balances.
The outlook is stable, reflecting Moody’s expectation that balance sheet measures and strong financial performance will be maintained over the next 12 to 18 months.
More articles on finance:
Texas cuts Planned Parenthood from Medicaid
Abbvie’s Viekira Pak: $6.5M a year in avoidable costs, and putting patients at greater risk
Value analysis: No longer the buzz word in healthcare, but a way of life
